Log in to save to my catalogue

Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3266776

Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

About this item

Full title

Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2012-02, Vol.122 (2), p.425-434

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Retinoblastoma is a pediatric retinal tumor initiated by biallelic inactivation of the retinoblastoma gene (RB1). RB1 was the first identified tumor suppressor gene and has defined roles in the regulation of cell cycle progression, DNA replication, and terminal differentiation. However, despite the abundance of work demonstrating the molecular func...

Alternative Titles

Full title

Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3266776

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3266776

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI57114

How to access this item